SANTA CLARA, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic ...
SANTA CLARA, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, ...
SANTA CLARA, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (SIBN), a Silicon Valley-based medical device company focused on sacropelvic surgical solutions, today confirmed that certain CD ...
Utah’s Public Employees Health Plan issued a positive coverage policy for SI joint fusions using SI-Bone’s iFuse Implant System. 1. The policy specifies coverage for minimally invasive SI joint ...
"We are happy to welcome Martin to our board of directors. Martin's extensive experience working with large and small commercial health plans will provide significant insight and guidance for us as we ...
SANTA CLARA, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic ...
"Almost 16,000 iFuse procedures have been performed and professional medical societies in the United States such as ISASS (International Society for the Advancement of Spine Surgery) have issued ...
The iFuse Bedrock Granite™ system is a Breakthrough Device Designation technology that provides pelvic fixation and sacroiliac joint fusion, in conjunction with lumbar spinal fusion procedures SANTA ...
More than 1.6 million spinal procedures are performed in the U.S. each year and between 10% and 30% of them fail to achieve their objective, indicating that the field has abundant room for improvement ...